Afuco™ Anti-Human CTAG1B ADCC Therapeutic Antibody (CTA-001), ADCC Enhanced
Anti-CTAG1B ADCC Enhanced Antibody (CTA-001) is an ADCC enhanced antibody produced by our Afuco™ platform. CTA001 is the first human-derived antibody against cancer-testis (CT) antigen NY-ESO-1, whitch efficiently inhibits the growth of tumors in mice acting synergistically with chemotherapy. It has great potential for defining a new therapeutic class in cancer medicine.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-183CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CTAG1B |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |